APOE genotype, plasma lipids lipoproteins, and AD in community elderly

被引:140
|
作者
Romas, SN
Tang, MX
Berglund, L
Mayeux, R [1 ]
机构
[1] Columbia Univ, Sch Med, Gertrude H Sergievsky Ctr, Taub Ctr Alzheimers Dis Res, New York, NY 10032 USA
[2] Columbia Univ, Sch Publ Hlth, Dept Med, New York, NY 10032 USA
[3] Columbia Univ, Sch Publ Hlth, Dept Neurol, New York, NY 10032 USA
[4] Columbia Univ, Sch Publ Hlth, Dept Psychiat, New York, NY 10032 USA
[5] Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY 10032 USA
[6] Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY 10032 USA
关键词
D O I
10.1212/WNL.53.3.517
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Genetic variation at the APOE locus has a major influence on both plasma lipid levels and the risk of AD. The relationship between APOE genotype and plasma lipids may influence the risk of AD. Objective: In a community-based study of white, African American, and Caribbean Hispanic elderly in New York City, we investigated the relationship between plasma lipids and AD as well as the possible influence of APOE genotype on this relationship. Methods: Total plasma cholesterol (TC), low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride levels were investigated in a cross-sectional study of nondemented elderly and patients with AD and in a prospective study of incident AD. Analyses included APOE genotype, gender, ethnicity, body mass index, and other potential confounders such as a history of hypertension, smoking, aspirin use, previous stroke, or ischemic heart disease. Results: Compared with nondemented elderly, decreased TC level had a weak but significant inverse association with incident AD, independent of APOE genotype. No other lipoprotein fragment was associated with either prevalent or incident AD. Conclusion: Our results suggest that no consistent relationship exists between APOE genotype, plasma lipoproteins, and AD.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 50 条
  • [41] SERUM-LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS IN THE HEALTHY ELDERLY
    WALLER, KV
    WARD, KM
    RUDMANN, SV
    LABORATORY MEDICINE, 1992, 23 (02) : 109 - 114
  • [42] EFFECTS OF AN ORAL CONTRACEPTIVE ON PLASMA LIPIDS AND LIPOPROTEINS
    SACHS, BA
    WOLFMAN, L
    CIRCULATION, 1968, 38 (4S6) : V169 - &
  • [43] EFFECTS OF ISOTRETINOIN ON PLASMA-LIPIDS AND LIPOPROTEINS
    不详
    NUTRITION REVIEWS, 1986, 44 (06) : 196 - 198
  • [44] Plasma lipids, lipoproteins and apolipoproteins in hirsute women
    CasteloBranco, C
    Casals, E
    deOsaba, MJM
    Sanllehy, C
    Fortuny, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1996, 75 (03) : 261 - 265
  • [45] Plasma lipids and lipoproteins in juvenile chronic arthritis
    Bakkaloglu, A
    Kirel, B
    Ozen, S
    Saatci, U
    Topaloglu, R
    Besbas, N
    CLINICAL RHEUMATOLOGY, 1996, 15 (04) : 341 - 345
  • [46] PLASMA-LIPIDS AND LIPOPROTEINS IN VEGETARIANS AND CONTROLS
    不详
    NUTRITION REVIEWS, 1975, 33 (09) : 285 - 286
  • [47] DIURETIC EFFECTS ON PLASMA-LIPIDS AND LIPOPROTEINS
    GRIMM, RH
    LEON, AS
    HUNNINGHAKE, D
    BLACKBURN, H
    CLINICAL RESEARCH, 1978, 26 (03): : A290 - A290
  • [48] PLASMA-LIPIDS, LIPOPROTEINS, AND MAMMOGRAPHIC DENSITIES
    BOYD, NF
    CONNELLY, P
    BYNG, J
    YAFFE, M
    DRAPER, H
    LITTLE, L
    JONES, D
    MARTIN, LJ
    LOCKWOOD, G
    TRITCHLER, D
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1995, 4 (07) : 727 - 733
  • [49] EFFECT OF CIMETIDINE ON PLASMA-LIPIDS AND LIPOPROTEINS
    HOOGWERF, BJ
    GRUND, VR
    HUNNINGHAKE, DB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) : 217 - 220
  • [50] Plasma lipids, lipoproteins and atherosclerosis of cerebral vessels
    Postiglione, A
    Napoli, C
    DArmiento, FP
    Ruocco, A
    DiMinno, G
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1997, 7 (03) : 231 - 236